Spinal Cord Stimulation for Depression via Raphe Nuclei Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for depression primarily rely on pharmaceutical approaches, such as selective serotonin reuptake inhibitors, which vary in effectiveness and have side effects, making it difficult to determine the best treatment for individual patients.
Innovation Solution
Applying electrical stimulation energy to afferent nerve fibers leading to the medial preoptic region of the hypothalamus, specifically to the raphe nuclei, to activate serotonin, thereby treating depression. This is achieved by implanting electrodes in the epidural space, such as the dorsal-lateral quadrant, and delivering electrical pulses to the afferent nerve fibers at spinal levels like S1-S3.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pharmaceutical compounds are used to treat depression, then serotonin generation and metabolism is improved, but effectiveness varies widely and side effects occur
Solution Approach 1:
The patent replaces the chemical/pharmaceutical system with an electrical stimulation system. Instead of using pharmaceutical compounds to modulate serotonin, the invention uses electrical pulses delivered through spinal cord stimulation to activate afferent nerve fibers, thereby substituting a mechanical/electrical intervention for a chemical one to achieve more reliable and controllable treatment of depression with fewer side effects.
2Reliability
If electrical stimulation is applied to activate serotonin in raphe nuclei, then depression treatment is achieved, but direct stimulation of brain structures requires complex surgical procedures
Solution Approach 1:
Instead of directly stimulating the raphe nuclei in the brain (which would require complex craniotomy and deep brain stimulation procedures), the invention inverts the approach by stimulating the afferent nerve fibers that project to the raphe nuclei through the spinal cord. This indirect stimulation pathway is accessed through the epidural space, which is much easier to reach surgically, thereby achieving the same therapeutic effect with reduced surgical complexity.
Solution Approach 2:
The patent introduces an intermediary pathway: electrical stimulation is applied to afferent nerve fibers in the spinal cord (via epidural electrodes), which then transmit signals to the medial preoptic region of the hypothalamus and ultimately to the raphe nuclei. This intermediary neural pathway allows indirect activation of serotonin-producing neurons without requiring direct access to the brain, simplifying the surgical procedure while maintaining treatment efficacy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively activates serotonin in the raphe nuclei, providing a therapeutic option for depression that complements existing pharmaceutical treatments by leveraging spinal cord stimulation to modulate mood disorders.
Implementation Method 1
electrical stimulation energy conveyed to the electrodes creates an electrical field, which, when strong enough, depolarizes (or 'stimulates') the neural fibers within the spinal cord beyond a threshold level, thereby inducing the firing of action potentials (APs)
Implementation Method 2
inducing the firing of action potentials (APs) that propagate along the neural fibers to provide the desired efficacious therapy to the patient
Data Source
AI summary
A method for treating a patient suffering from depression, the method including applying electrical stimulation energy to afferent nerve fibers leading to the medial preoptic region of the hypothalamus of the patient, thereby activating serotonin in the raphe nuclei to treat depression.